← All companies
Algen Biotechnologies
ActiveUsing CRISPR to find treatments for cancer and inflammation
Winter 2020Founded 201813 peopleSan Francisco, CA, USA
About
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.
Founders · 2
Formerly “Algen Biotechnologies”, “Inc.”
Related startups
Sequence BioSummer 2019
Discovering the true signals of disease to power life-changing drugs.
Active
Abalone BioWinter 2020
We create activating antibodies to treat diseases others can’t.
Active
